Skip to main content

News

PURDUE PHARMA (CANADA) APPOINTS ANDRÉ CÔTÉ VICE PRESIDENT, HEALTH SOLUTIONS

Published on May 22, 2018

PICKERING, ON, May 22, 2018 /CNW/ — André Côté is appointed Vice President, Health Solutions…

Read More

Purdue Pharma (Canada) appoints Melanie Milburn Vice President of Marketing

Published on May 2, 2018

PICKERING, ON, May 2, 2018 – Melanie Milburn is appointed Vice President Marketing after successfully…

Read More

PENTHROX® RECEIVES MARKETING AUTHORIZATION FROM HEALTH CANADA FOR ADULT PATIENTS REQUIRING RELIEF FROM MODERATE TO SEVERE ACUTE PAIN ASSOCIATED WITH TRAUMA OR INTERVENTIONAL MEDICAL PROCEDURES

Published on April 10, 2018

Pickering, ON (Canada) (April 10, 2018): Purdue Pharma (Canada) and Medical Developments International Limited (MDI),…

Read More

NEW TREATMENT OPTION FOR ADULTS WITH ADHD: FOQUEST™ (METHYLPHENIDATE CONTROLLED RELEASE CAPSULES) NOW AVAILABLE IN CANADA

Published on February 1, 2018

First and only methylphenidate product approved in Canada with a 16-hour duration of action PICKERING,…

Read More

ARCHIVE

2018
2017
2016
2015
2014
2013
2012

For all media inquiries, please contact:

media@purdue.ca

↓